Filing Details
- Accession Number:
- 0001493152-23-002844
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2023-01-30 06:10:12
- Reporting Period:
- 2022-12-31
- Accepted Time:
- 2023-01-30 06:10:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552189 | Panacea Life Sciences Holdings Inc. | PLSH | Medicinal Chemicals & Botanical Products (2833) | 271085858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866792 | Leslie Buttorff | 5910 South University Blvd, C18-193 Greenwood Village CO 80121 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-18 | 1,100 | $0.71 | 662,049 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-01-19 | 1,000 | $0.71 | 663,049 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-01-20 | 2,300 | $0.66 | 665,349 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-01-25 | 700 | $0.85 | 666,049 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-02-11 | 200 | $0.69 | 666,249 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-02-16 | 100 | $0.70 | 666,349 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-05-16 | 200 | $0.42 | 666,549 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-05-17 | 100 | $0.50 | 666,649 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-05-23 | 100 | $0.50 | 666,749 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 300 | $0.43 | 667,049 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-14 | 500 | $0.18 | 667,549 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-16 | 500 | $0.13 | 668,049 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-17 | 9,600 | $0.28 | 677,649 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-21 | 3,700 | $0.39 | 681,349 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-06-29 | 2,500 | $0.30 | 683,849 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-07-14 | 200 | $0.45 | 686,549 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-07-15 | 400 | $0.42 | 686,949 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-07-22 | 400 | $0.29 | 687,349 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-07-26 | 1,100 | $0.12 | 688,449 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-08-09 | 1,000 | $0.14 | 689,449 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-08-11 | 2,000 | $0.13 | 691,449 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-08-18 | 1,000 | $0.17 | 692,449 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-08-19 | 6,500 | $0.16 | 698,949 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-09-13 | 1,000 | $0.10 | 699,949 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-11-23 | 3,000 | $0.10 | 702,949 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-11-29 | 2,000 | $0.13 | 704,949 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-12-01 | 1,000 | $0.10 | 705,949 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |